Alex Thurman
Direttore Finanziario/CFO presso GLAUKOS CORPORATION
Patrimonio netto: 6 M $ in data 31/05/2024
Profilo
Alex Thurman is currently the Chief Financial Officer & Senior Vice President at Glaukos Corp.
and the Vice President-Finance at Allergan Ltd.
(Ireland).
He has an undergraduate and graduate degree from Brigham Young University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
GLAUKOS CORP
0.10% | 10/05/2024 | 51 647 ( 0.10% ) | 6 M $ | 31/05/2024 |
Posizioni attive di Alex Thurman
Società | Posizione | Inizio |
---|---|---|
GLAUKOS CORPORATION | Direttore Finanziario/CFO | 01/04/2022 |
ALLERGAN PLC | Direttore Finanziario/CFO | 01/12/2016 |
Formazione di Alex Thurman
Brigham Young University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
GLAUKOS CORPORATION | Health Technology |
Aziende private | 1 |
---|---|
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
- Borsa valori
- Insiders
- Alex Thurman